Status:
TERMINATED
A Study of Abatacept in Patients With Active Crohn's Disease
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Crohn's Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active Crohn's Disease in patients who have not had an adequate response to other therapies. The ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18 years or older
- have had Crohn's Disease for at least 3 months
- moderate to severely active Crohn's Disease
- have had an inadequate response or intolerance to other Crohn's Disease treatments
Exclusion
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
451 Patients enrolled
Trial Details
Trial ID
NCT00406653
Start Date
December 1 2006
End Date
November 1 2009
Last Update
September 14 2010
Active Locations (101)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Alabama Medical Center
Birmingham, Alabama, United States, 35294
2
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
3
The Permanente Medical Group, Inc
Sacramento, California, United States, 95825
4
University Of Florida
Gainesville, Florida, United States, 32610